Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.04.025

Cited by (952)

Items 401–500 of 952

  1. TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis
    Jesse Gore, Kelly E. Craven, Julie L. Wilson, Gregory A. Coté, Monica Cheng, Hai V. Nguyen, Harvey M. Cramer, Stuart Sherman, Murray Korc · 2015 · Oncotarget
  2. Molecular Pathways: Myeloid Complicity in Cancer
    Ingunn M. Stromnes, Philip D. Greenberg, Sunil R. Hingorani · 2014 · Clinical Cancer Research
  3. Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway
    Chih-Hsin Kuo, Kuei-Fang Chen, Shah‐Hwa Chou, Ya‐Fang Huang, Cheng‐Ying Wu, Da-En Cheng, Yuwen Chen, Chih‐Jen Yang, Jen‐Yu Hung, Ming‐Shyan Huang · 2013 · Carcinogenesis
  4. Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
    Patrícia Dias Carvalho, Ana Luísa Machado, Flávia Martins, Raquel Seruca, Sérgia Velho · 2019 · Cancers
  5. More than a scaffold: Stromal modulation of tumor immunity
    Anna Johansson, Juliana Hamzah, Ruth Ganß · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis
    Yungang Wang, Jie Tian, Shengjun Wang · 2015 · Seminars in Arthritis and Rheumatism
  7. MSCs and inflammation: new insights into the potential association between ALCL and breast implants
    Monia Orciani, Giulia Sorgentoni, Matteo Torresetti, Roberto Di Primio, Giovanni Di Benedetto · 2016 · Breast Cancer Research and Treatment
  8. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer
    Jinglong Guo, Siyue Wang, Qi Gao · 2023 · Frontiers in Immunology
  9. The receptor for advanced glycation end products: A fuel to pancreatic cancer
    Uzma Shahab, Mohd. Kaleem Ahmad, Abbas Ali Mahdi, Mohd. Waseem, Binish Arif, Moinuddin Moinuddin, Saheem Ahmad · 2017 · Seminars in Cancer Biology
  10. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis
    Anusha Thadi, Marian Khalili, William F. Morano, Scott Daniel Richard, Steven Katz, Wilbur Bo Bowne · 2018 · Vaccines
  11. Prognostic values and immune suppression of the S100A family in pancreatic cancer
    Hongkai Zhuang, Xinming Chen, Fengying Dong, Zedan Zhang, Zixuan Zhou, Zuyi Ma, Shanzhou� Huang, Bo Chen, Chuanzhao Zhang, Baohua Hou · 2021 · Journal of Cellular and Molecular Medicine
  12. Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer
    Francesco De Sanctis, Alessia Lamolinara, Federico Boschi, Chiara Musiu, Simone Caligola, Rosalinda Trovato, Alessandra Fiore, Cristina Frusteri, Cristina Anselmi, Ornella Poffe et al. · 2022 · Journal for ImmunoTherapy of Cancer
  13. The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
    Marka R. Crittenden, Talicia Savage, Benjamin Cottam, Keith S. Bahjat, William L. Redmond, Shelly Bambina, Melissa J. Kasiewicz, Pippa Newell, Andrew Mark Jackson, Michael J. Gough · 2013 · PLoS ONE
  14. MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression
    Shiyue Mei, Jiaxuan Xin, Yu Liu, Yuan Zhang, Xue Liang, Xiaomin Su, Hui Yan, Yugang Huang, Rongcun Yang · 2015 · PLoS ONE
  15. GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
    Sandra Baumgart, NM Chen, Jin‐San Zhang, Daniel D. Billadeau, Irina N. Gaisina, Alan P. Kozikowski, Shiv K. Singh, Daniel Fink, Philipp Ströbel, Caroline Klindt et al. · 2016 · Molecular Cancer Therapeutics
  16. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy
    Neha Kamran, Mayuri Chandran, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2016 · Clinical Immunology
  17. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer
    Sabrina H. L. Hoffmann, Dorothea I. Reck, Andreas Maurer, Birgit Fehrenbacher, Jaclyn Sceneay, Marilena Poxleitner, Hasan Halit Öz, Walter Ehrlichmann, Gerald Reischl, Kerstin Fuchs et al. · 2019 · Theranostics
  18. Association between periodontitis and inflammatory comorbidities: The common role of innate immune cells, underlying mechanisms and therapeutic targets
    Qibing Wu, Weijia Zhang, Yaqiong Lu, Hongxia Li, Yaru Yang, Fengxue Geng, Jinwen Liu, Lin Li, Yaping Pan, Chen Li · 2024 · International Immunopharmacology
  19. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF
    Yanni Wang, Christy A. Thomson, Lenka L. Allan, Linda M. Jackson, Melanie Olson, Timothy R. Hercus, Tracy L. Nero, Amanda L. Turner, Michael W. Parker, Angel L. Corbí Lopez et al. · 2013 · Proceedings of the National Academy of Sciences
  20. Immune Therapy in GI Malignancies: A Review
    Judy Wang, Kim A. Reiss, Rina G. Khatri, Elizabeth M. Jaffee, Dan A. Laheru · 2015 · Journal of Clinical Oncology
  21. Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis
    Stacy K. Thomas, Jesse Lee, Gregory Lawrence Beatty · 2020 · EBioMedicine
  22. Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer
    Krystal Villalobos-Ayala, Ivannie Ortiz-Rivera, Ciara Alvarez, Kazim M. Husain, DeVon DeLoach, Gerald Krystal, Margaret L. Hibbs, Kun Jiang, Tomar Ghansah · 2020 · Cancers
  23. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled
    Ronit Vogt Sionov · 2021 · Cells
  24. Tofacitinib Facilitates the Expansion of Myeloid‐Derived Suppressor Cells and Ameliorates Arthritis in SKG Mice
    Keisuke Nishimura, Jun Saegusa, Fumichika Matsuki, Kengo Akashi, Goichi Kageyama, Akio Morinobu · 2014 · Arthritis & Rheumatology
  25. HPV and the Risk of HIV Acquisition in Women
    Romaniya Zayats, Thomas T. Murooka, Lyle R. McKinnon · 2022 · Frontiers in Cellular and Infection Microbiology
  26. KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy
    Priyanka Uniyal, Vivek Kumar Kashyap, Tapan Behl, Deepak Parashar, Ravi Rawat · 2025 · Cancers
  27. Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer
    Michael R. Ludwig, Kyoko Kojima, Gregory J. Bowersock, Dongquan Chen, Nirag Chandrakant Jhala, Donald J. Buchsbaum, William E. Grizzle, Christopher A. Klug, James A. Mobley · 2015 · PROTEOMICS
  28. Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer
    Supriya Srinivasan, Tulasigeri M. Totiger, Chanjuan Shi, Jason A. Castellanos, Purushottam Lamichhane, Austin R. Dosch, Fanuel Messaggio, Nilesh Kashikar, Kumaraswamy Malleshappa Honnenahally, Yuguang J. Ban et al. · 2018 · Cancer Research
  29. Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment
    Patrick G. Schweickert, Yi Yang, Emily White, Gregory M. Cresswell, Bennett D. Elzey, Timothy L. Ratliff, Paritha I. Arumugam, Silvio Antoniak, Nigel Mackman, Matthew J. Flick et al. · 2020 · Journal of Thrombosis and Haemostasis
  30. Neutrophils: Critical components in experimental animal models of cancer
    Catharina Hagerling, Zena Werb · 2016 · Seminars in Immunology
  31. Strict Requirement for Vector-Induced Type I Interferon in Efficacious Antitumor Responses to Virally Encoded IL12
    Ignacio Melero, Jose Ignacio Quetglas, Mercedes Reboredo, Juan Dubrot, Juan R. Rodríguez-Madoz, Uxua Mancheño, Erkuden Casales, José Ignacio Riezu‐Boj, Marta Ruiz-Guillen, María Carmen Ochoa et al. · 2014 · Cancer Research
  32. Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
    Audry Fernández, Liliana Oliver, Rydell Álvarez-Arzola, Luis Enrique Fernandez, Kelvin P. Lee, Circe Mesa · 2014 · Human Vaccines & Immunotherapeutics
  33. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3
    Min Ma, Wei Jiang Huang, Dehua Kong · 2018 · International Immunopharmacology
  34. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
    Clara S. Mundry, Kirsten C. Eberle, Pankaj K. Singh, Michael Anthony Hollingsworth, Kamiya Mehla · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  35. Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
    Faran Polani, Patrick M. Grierson, Kian‐Huat Lim · 2021 · World Journal of Gastroenterology
  36. The delicate balance of macrophages in colorectal cancer; their role in tumour development and therapeutic potential
    Rens Braster, Marijn Bögels, Robert H.J. Beelen, Marjolein van Egmond · 2015 · Immunobiology
  37. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer
    Jinhoi Song, Jaemin Lee, Jinsil Kim, Seongyea Jo, Yeon‐Jeong Kim, Ji Eun Baek, Eun‐Soo Kwon, Kwang‐Pyo Lee, Siyoung Yang, Ki‐Sun Kwon et al. · 2016 · Oncotarget
  38. Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases
    Dorota Magdalena Radomska-Leśniewska, Agata Białoszewska, Paweł Kamiński · 2021 · Cells
  39. Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
    Mara H. Sherman, Marina Pasca di Magliano · 2023 · Annual Review of Cancer Biology
  40. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
    Christian Alexander Bauer, Alexander Sterzik, Franz Georg Bauernfeind, Peter Duewell, Claudius H. Conrad, Rosemarie Kiefl, Stefan Endres, Andreas Eigler, Max M. Schnurr, Marc Dauer · 2014 · Cancer Immunology Immunotherapy
  41. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling
    Benjamin Kühnemuth, Leonie Mühlberg, Michael Schipper, Heidi Griesmann, Albrecht Neeße, Nada Milosevic, Thaddeus Till Wissniowski, Malte Buchholz, Thomas Mathias Gress, Patrick Michl · 2013 · Oncogene
  42. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers
    Federica Riccardo, Maddalena Arigoni, Genny Buson, Elisa Debora Zago, Manuela Iezzi, Dario Livio Longo, Matteo Carrara, Alessandra Fiore, Simona Nuzzo, Silvio Bicciato et al. · 2014 · BMC Genomics
  43. Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
    Jie Wang, Xiaobo Bo, Tao Suo, Han Liu, Xiaoling Ni, Sheng Shen, Min Li, Jiejie Xu, Houbao Liu, Yueqi Wang · 2018 · Cancer Science
  44. Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations
    Stéphane Renaud, Joseph Seitlinger, Yaseen Al Lawati, Francesco Guerrera, Pierre‐Emmanuel Falcoz, Gilbert Massard, Lorenzo Edwin Ferri, Jonathan David Spicer · 2018 · Annals of Surgery
  45. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression
    Huifeng Gao, Chien‐shan Cheng, Jian Tang, Ye Li, Hao Chen, Zhiqiang Meng, Zhen Chen, Lianyu Chen · 2020 · Aging
  46. Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
    Mengni He, Mackenzie Henderson, Stephen Muth, A. Murphy, Lei Zheng · 2020 · Annals of Pancreatic Cancer
  47. Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
    Anik Pramanik, Sankar Bhattacharyya · 2022 · Life Sciences
  48. Hepatic myeloid-derived suppressor cells in cancer
    José Medina‐Echeverz, Tobias Eggert, Miaojun Han, Tim F. Greten · 2015 · Cancer Immunology Immunotherapy
  49. Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms
    Norman Fultang, Xinyuan Li, Ting Li, Youhai H. Chen · 2021 · Frontiers in Immunology
  50. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
    Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin · 2023 · Cancer Letters
  51. Dynamic Interplay of Oncogenes and T Cells Induces PD-L1 in the Tumor Microenvironment
    Andrew J. Rech, Robert H. Vonderheide · 2013 · Cancer Discovery
  52. Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages
    Dörthe Masemann, Katharina Köther, Meike Kuhlencord, Georg Varga, Johannes Roth, Brian Dennis Lichty, Ulf Rüdiger Rapp, Viktor Wixler, Stephan Ludwig · 2018 · OncoImmunology
  53. Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives
    Elahe Safari, Sajjad Ghorghanlu, Homayoun Ahmadi‐khiavi, Sahar Mehranfar, Ramazan Rezaei, Morteza Motallebnezhad · 2018 · Journal of Cellular Physiology
  54. The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms
    Wu-Hu Zhang, Wenquan Wang, He-Li Gao, Xianjun Yu, Liang Liu · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  55. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
    Shivani Malik, Jill M. Westcott, Rolf A. Brekken, Francis J. Burrows · 2021 · Cancers
  56. Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer
    И. В. Алексеенко, Eugene V. Snezhkov, И. П. Чернов, Victor V. Pleshkan, Victor K. Potapov, Alexander V. Sass, Galina S. MONASTYRSKAYA, E. P. Kopantzev, Tatyana V Vinogradova, Yuri V. Khramtsov et al. · 2015 · Journal of Translational Medicine
  57. Tumor-Induced Myeloid-Derived Suppressor Cells
    Francesco De Sanctis, Vincenzo Bronte, Stefano Ugel · 2016 · Microbiology Spectrum
  58. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration
    Ryuji Yamaguchi, Guy A Perkins · 2018 · Cancer Biology & Therapy
  59. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
    Kai Wang, Graham S. Baldwin, Mehrdad Nikfarjam, Hong Zhen He · 2018 · World Journal of Gastroenterology
  60. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
    Wei Mu, Zhe Wang, Margot Zöller · 2019 · Frontiers in Oncology
  61. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations
    Qiaofei Liu, Ronghua Zhang, Xiang Zhang, Jingkai Liu, Huanwen Wu, Yuan Li, Ming Cui, Tong Li, Huixin Song, Junyi Gao et al. · 2021 · Cancer Immunology Immunotherapy
  62. Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth
    Anita Bodac, Abdullah Mayet, Sarika Rana, Justine Pascual, Amber D. Bowler, Vincent Roh, Nadine Fournier, Ligia Craciun, Pieter Demetter, Freddy Radtke et al. · 2023 · EMBO Molecular Medicine
  63. GM‐CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid‐derived suppressor cells in vitro
    Tessa Gargett, Susan N. Christo, Timothy R. Hercus, Muhammad Nazim Abbas, Nimit Singhal, Angel Francisco Lopez, Michael Paul Brown · 2016 · Clinical & Translational Immunology
  64. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma
    Ishan Roy, Kathleen A. Boyle, Emily P. Vonderhaar, Noah P. Zimmerman, Egal Gorse, Alexander Craig Mackinnon, Rosa F. Hwang, Janusz Franco‐Barraza, Edna Cukierman, Susan Tsai et al. · 2017 · Laboratory Investigation
  65. MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer
    Ning Ma, Qilin Liu, Lin Hou, Yalin Wang, Ziling Liu · 2017 · International Journal of Immunopathology and Pharmacology
  66. An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer
    Yaqiong Chen, Zhi Jie Zhao, Yu Chen, Zhonglin Lv, Xin Ding, Renxi Wang, Xiao He, Chunmei Hou, Beifen Shen, Jiannan Feng et al. · 2017 · Scientific Reports
  67. Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
    Rie Iida‐Norita, Minaho Kawamura, Yasuhiro Suzuki, Shin Hamada, Atsushi Masamune, Toru Furukawa, Yasufumi Sato · 2019 · Cancer Science
  68. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer
    Yoshinori Kajiwara, Hiroshi Tazawa, Motohiko Yamada, Nobuhiko Kanaya, Takuro Fushimi, Satoru Kikuchi, Shinji Kuroda, Toshiaki Ohara, Kazuhiro Noma, Ryuichi Yoshida et al. · 2022 · Cancer Immunology Immunotherapy
  69. Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
    Yan Li, Renee B. Chang, Meredith L. Stone, Devora Delman, Kelly Markowitz, Yuqing Xue, Heather Coho, Veronica M. Herrera, Joey H. Li, Liti Zhang et al. · 2024 · Cell Reports Medicine
  70. Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
    Paul E. Oberstein, Andressa Dias Costa, Emily A. Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri, Harshabad Singh, Thomas Adam Abrams, Leah H. Biller, James M. Cleary et al. · 2024 · Cancer Immunology Research
  71. A clinical perspective on the role of chronic inflammation in gastrointestinal cancer
    Hana Alguel, Sebastian Rasch · 2014 · Clinical and Experimental Gastroenterology
  72. Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
    Daniel Delitto, Shannon Margaret Wallet, Steven J. Hughes · 2016 · Pharmacology & Therapeutics
  73. K RAS mutation and epithelial–macrophage interplay in pancreatic neoplastic transformation
    Faraz Bishehsari, Lijuan Zhang, Usman Barlass, Nailliw Z. Preite, Sanja B. Turturro, Matthew S. Najor, Brandon Shetuni, Janet P. Zayas, Mahboobeh Mahdavinia, Abde M. Abukhdeir et al. · 2018 · International Journal of Cancer
  74. Animal Models
    Jami L. Saloman, Kathryn M. Albers, Zobeida Cruz‐Monserrate, Brian M. Davis, Mouad Edderkaoui, Guido Eibl, Ariel Y. Epouhe, Jeremy Y. Gedeon, Fred S. Gorelick, Paul J. Grippo et al. · 2019 · Pancreas
  75. TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma
    Kasia Trebska-McGowan, Mehdi Chaib, Marcus A. Alvarez, Rita G. Kansal, Ajeeth Kumar Pingili, David Shibata, Liza Makowski, Evan Scott Glazer · 2021 · Journal of Gastrointestinal Surgery
  76. Critical role of oncogenic KRAS in pancreatic cancer (Review).
    Jiang Liu, S. Ji, Chen Liang, Yi Qin, K. Jin, Ding-Kong Liang, W. Xu, S. Shi, Bo Zhang, Liang Liu et al. · 2016 · Molecular Medicine Reports
  77. HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model
    Tao Yin, Sisi He, Guobo Shen, Yongsheng Wang · 2015 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  78. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes
    Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang, Jae-Joon Kim · 2023 · Cancers
  79. Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
    Rong Jiao, Xia Lin, Qian Zhang, Yan Zhang, Wen Qin, Qiaoling Yang, Chuan Shan Xu, Fubo Chen, Kun Zhang · 2023 · Progress in Materials Science
  80. Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
    Hiroshi Yano, Archana B. Thakur, Elyse N. Tomaszewski, Minsig Choi, Abhinav Deol, Lawrence G. Lum · 2014 · Journal of Translational Medicine
  81. Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway
    Yanling Sun, Zu’an Zheng, Huafeng Zhang, Yuandong Yu, Jingwei Ma, Ke Tang, Pingwei Xu, Tiantian Ji, Xiaoyu Liang, Degao Chen et al. · 2017 · OncoImmunology
  82. Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
    Benjamin D. Medina, Mengyuan Liu, Gerardo A. Vitiello, Adrian M. Seifert, Shan Zeng, Timothy Geoffrey Bowler, Jennifer Q. Zhang, Michael J. Cavnar, Jennifer K. Loo, Nesteene Joy Param et al. · 2019 · The Journal of Experimental Medicine
  83. Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
    А. V. Ponomarev, Irina Zh. Shubina · 2019 · Frontiers in Oncology
  84. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
    Philipp Metzger, Sabrina Viktoria Kirchleitner, Michael Kluge, Lars M. König, Christine Hörth, Carlotta A. Rambuscheck, Daniel Böhmer, Julia Ahlfeld, Sebastian Kobold, Caroline C. Friedel et al. · 2019 · Journal for ImmunoTherapy of Cancer
  85. From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
    Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti et al. · 2020 · Cells
  86. Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
    Zhitao Wang, Rui Jiang, Qian Li, Huiping Wang, Qianshan Tao, Zhimin Zhai · 2021 · Journal of Clinical Medicine
  87. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment
    Emily A. Jesser, Nicholas J. Brady, Danielle N. Huggins, Patrice M. Witschen, Christine H. O’Connor, Kathryn L. Schwertfeger · 2021 · Breast Cancer Research
  88. Strategies for Heating Up Cold Tumors to Boost Immunotherapies
    Daniel J. Zabransky, Mark M. Yarchoan, Elizabeth M. Jaffee · 2023 · Annual Review of Cancer Biology
  89. Nicotinamide N-methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma
    Yang Li, Bo Yang, Huijie Miao, Liguo Liu, Ziyi Wang, Chengkai Jiang, Yang Yang, Shimei Qiu, Xuechuan Li, Yajun Geng et al. · 2023 · Hepatology
  90. Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species
    Anurag Singh, Felipe Lelis, Stefanie Braig, Iris Schäfer, Dominik Hartl, Nikolaus Peter Rieber · 2016 · Frontiers in Microbiology
  91. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages
    Michele L. Babicky, Megan M. Harper, Jeffery M. Chakedis, Alex Cazes, Evangeline Sari. Mose, Dawn V. Jaquish, Randall P. French, Betzaira G. Childers, Hakan Alakus, Michael C. Schmid et al. · 2019 · Oncogene
  92. Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer
    Daniel Delitto, Chelsey Perez, Song Han, David Hernández Gonzalo, Kien Pham, Andrea E. Knowlton, Christina L. Graves, K.E. Behrns, Lyle L. Moldawer, Ryan Michael Thomas et al. · 2015 · Cancer Immunology Immunotherapy
  93. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation
    J. Pablo Arnoletti, Xiang Zhu, Alvin J.O. Almodovar, Paula P. Veldhuis, Ryan Sause, Elizabeth Griffith, George Corpus, Jeffrey C.C. Chang, Na’im Fanaian, Sally A. Litherland · 2016 · Pancreas
  94. Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis
    Wen‐Chi Wei, Sheng‐Yen Lin, Chun‐Wen Lan, Yuchen Huang, Chih‐Yu Lin, Pei‐Wen Hsiao, Yet‐Ran Chen, Wen‐Chin Yang, Ning‐Sun Yang · 2016 · Scientific Reports
  95. Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment
    William D. Green, Amber Gomez, Alec L. Plotkin, Brandon M. Pratt, Emily F. Merritt, Genevieve Nicole Mullins, Nancy Porterfield Kren, Jennifer L. Modliszewski, Vasyl Zhabotynsky, Mark G. Woodcock et al. · 2025 · Immunity
  96. Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
    Huey-Jen L. Lin, Jiayuh Lin · 2017 · Cancers
  97. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment
    Jaclyn Sceneay, Christoph M. Griessinger, Sabrina H. L. Hoffmann, Shu Wen, Christina S.F. Wong, Sophie Krumeich, Manfred Kneilling, Bernd Jürgen Pichler, Andreas Möller · 2018 · PLoS ONE
  98. FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer
    H. Zhuang, C. Zhang, Baohua Hou · 2020 · Clinical & Translational Oncology
  99. Brief review on the roles of neutrophils in cancer development
    Long Wang, Jingjing Chen, Gao Chen, Zhi Lin, Xubiao Xie, Helong Dai · 2020 · Journal of Leukocyte Biology
  100. Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
    Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2021 · Cancer Immunology Research